Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 7:12:e17302.
doi: 10.7717/peerj.17302. eCollection 2024.

Effect of iron saturation of bovine lactoferrin on the inhibition of hepatitis B virus in vitro

Affiliations

Effect of iron saturation of bovine lactoferrin on the inhibition of hepatitis B virus in vitro

Haibo Zhou et al. PeerJ. .

Abstract

Background: Hepatitis B virus (HBV) infection poses a major public health problem worldwide. Bovine lactoferrin (bLf) is a natural product that can inhibit HBV, but the effect of iron saturation on its resistance to HBV is unknown.

Aims: The purpose of this study is to investigate the impact of iron saturation of bLf against HBV.

Methods: HepG2 cells were cultured in DMEM high glucose containing 10% inactivated fetal calf serum, at 37 °C, in 5% CO2. MTT method was used to detect the cytotoxicity of bLf to HepG2 cells. Apo-bLf and holo-bLf were prepared from bLf. Iron saturation of these proteins was determined by atomic absorption spectrophotometry. Non-cytotoxic concentrations of candidate proteins were used in anti-HBV tests. Fluorescent quantitative polymerase chain reaction was used to detect HBV-DNA.

Results: The TC50 and TC0of bLf were 54.570 mg/ml and 1.997 mg/ml, respectively. The iron saturation of bLf, apo-bLf and holo-bLf were 10.29%, 8.42% and 85.32%, respectively. In this study, four non-cytotoxic concentrations of candidate proteins (1.5, 1.0, 0.5, and 0.1 mg/ml, respectively) were used to inhibit HBV in HepG2 cells. The results showed that 1.5 mg/ml bLf and 0.1 mg/ml holo-bLf effectively impaired the HBV-DNA amplification in HBV-infected HepG2 cells (P < 0.05). However, apo-bLf, and Fe3+ did not show the anti-HBV effects.

Conclusion: A total of 1.5 mg/ml bLf and 0.1 mg/ml holo-bLf could inhibit HBV-DNA in HepG2 cells. Complete bLf structure, appropriate concentration and iron saturation of bLf are necessary conditions for anti-HBV effects.

Keywords: Bovine lactoferrin; HepG2 cell; Hepatitis B virus; Iron saturation; Polymerase chain reaction.

PubMed Disclaimer

Conflict of interest statement

Yiwei Zhu is an employee of Chongqing Food Industry Research Institute Co., Ltd.

Figures

Figure 1
Figure 1. (A) Electrophoretogram of lactoferrin with different iron saturation. (B) The standard curve of iron saturation of lactoferrin. (C) Fluorescence spectra of lactoferrin with different iron saturation.
Figure 2
Figure 2. (A) Standard curve of HBV DNA detected by FQ-PCR. (B) FQ-PCR amplification curves of standard, the concentrations of standards are 1 ×108 copies/ml, 1 ×107 copies/ml, 1 ×106 copies/ml, 1 ×105 copies/ml, 1 ×104 copies/ml, respectively.
Figure 3
Figure 3. The effect of candidate agents inhibits HBV.
Non-toxic concentrations of each protein are 1.5, 1.0, 0.5 and 0.1 mg/ml, respectively. 2,500 IU/ml IFN-alpha and 6 μg/ml FeCl3 were involved in this test. The infected cells without any treatment are defined as positive groups. Y-axis represents the natural logarithm of HBV copies/ml. (A) Inhibition of bLf on HBV virus. (B) Inhibition of apo-bLf on HBV virus. (C) Inhibition of holo-bLf on HBV virus. (D) Inhibition of Fe3+ on HBV virus.

Similar articles

Cited by

References

    1. Anderson BF, Baker HM, Norris GE, Rumball SV, Baker EN. Apolactoferrin structure demonstrates ligand-induced conformational change in transferrins. Nature. 1990;344(6268):784–787. doi: 10.1038/344784a0. - DOI - PubMed
    1. Ascione A, Ascione T, Lanza AG, Utech W, Di Costanzo GG, Macri M. Factors influencing outcome of lamivudine in anti-HBe-positive chronic hepatitis B. Hepatogastroenterology. 2006;53(72):919–923. - PubMed
    1. Baker HM, Baker CJ, Smith CA, Baker EN. Metal substitution in transferrins: specific binding of cerium(IV) revealed by the crystal structure of cerium-substituted human lactoferrin. Journal of Biological Inorganic Chemistry. 2000;5(6):692–698. doi: 10.1007/s007750000157. - DOI - PubMed
    1. Baker HM, Baker EN. A structural perspective on lactoferrin function. Biochemistry and Cell Biology. 2012;90(3):320–328. doi: 10.1139/o11-071. - DOI - PubMed
    1. Carvalho CA, Sousa Jr IP, Silva JL, Oliveira AC, Goncalves RB, Gomes AM. Inhibition of Mayaro virus infection by bovine lactoferrin. Virology. 2014;452–453:297–302. doi: 10.1016/j.virol.2014.01.022. - DOI - PubMed

Publication types